LEADS: Agent-Driven Discovery of Hybrid Structures for Cardiac Electrophysiology Digital Twins

Background and Context

The development of personalized cardiac electrophysiology digital twins represents a critical frontier in precision medicine, yet it has long been hindered by the complexity of model structure selection. The core challenge lies not merely in fitting parameters within existing mathematical frameworks, but in identifying and constructing the most appropriate model architecture for each individual patient. Traditional modeling approaches have historically relied heavily on the expertise of domain specialists who manually design hybrid architectures combining physical equations with neural networks. This manual process is not only time-intensive and laborious but also struggles to generalize effectively across different patient populations. The high barrier to entry for such expertise limits the scalability of digital twin applications in clinical settings.

Recent advancements in large language models (LLMs) have introduced new possibilities for automated model generation. Some studies have attempted to leverage LLMs to generate or act as components of hybrid models, demonstrating a degree of generalization potential. However, these methods often lack the necessary structural priors specific to cardiac electrophysiology. Without these domain-specific constraints, LLM-generated models frequently suffer from instability in simulations or fail to adhere to fundamental physical laws. This gap between the generative power of LLMs and the rigorous stability requirements of biological simulations has created a bottleneck in the field, preventing the widespread adoption of fully automated, high-fidelity digital twins.

To address these limitations, the LEADS framework has been proposed as a novel solution. LEADS aims to bridge the gap between the flexibility of AI-driven discovery and the rigor of physical modeling. By formalizing electrophysiological domain knowledge into a structured action space, LEADS enables LLM agents to iteratively reason and act in discovering, composing, and optimizing hybrid model structures. This approach marks a significant paradigm shift from manual design to intelligent discovery, offering a robust pathway for creating personalized medical models that are both physically interpretable and numerically stable.

Deep Analysis

The technical architecture of the LEADS framework is built upon an iterative loop of reasoning and action, allowing LLM agents to operate similarly to human researchers. Within a structured action space, the agent autonomously decides how to select, combine, and refine the various components of a hybrid model based on real-time simulation feedback. This mechanism facilitates an open-ended exploration of architectures while strictly maintaining physical interpretability. The agent is designed to discover innovative structures that might be overlooked by human experts, leveraging the vast latent space of possible model configurations without sacrificing the grounding in physical reality.

A key innovation in LEADS is the decoupling of structure search from parameter optimization. While the LLM agent focuses on discovering the optimal hybrid structure, the framework employs gradient descent algorithms for efficient parameter fitting within each generated architecture. This separation ensures that the structural search is not hindered by the computational cost of full optimization during the discovery phase. Furthermore, every candidate model generated by the agent is subjected to strict design constraints. These constraints guarantee that the resulting models possess physical grounding, interpretability, and numerical stability, thereby mitigating the "black box" risks and numerical divergence issues commonly associated with purely data-driven deep learning approaches.

The framework’s hybrid strategy effectively balances the credibility of physical models with the nonlinear fitting capabilities of neural networks. By embedding domain knowledge directly into the agent’s decision-making process through the structured action space, LEADS ensures that the generated models remain relevant to the underlying biology. This approach avoids the common pitfall of LLMs generating syntactically correct but physically meaningless structures. The integration of gradient descent for parameter fitting further enhances the precision of the models, allowing them to accurately replicate the complex dynamics of cardiac electrophysiology.

Industry Impact

The implications of the LEADS framework extend across multiple sectors, including the open-source community, industrial applications, and future research directions. For the open-source community, LEADS provides a reproducible, agent-based tool for model discovery, significantly lowering the barrier to entry for complex biophysical modeling. This accessibility fosters interdisciplinary collaboration and innovation, allowing researchers from diverse fields to contribute to and benefit from advanced digital twin technologies. The framework’s emphasis on transparency and physical interpretability aligns with the growing demand for trustworthy AI in scientific research.

In the industrial sector, the automated and efficient modeling workflow offered by LEADS has the potential to accelerate the development of personalized diagnostic and treatment planning systems for heart disease. By reducing the time and expertise required to build accurate digital twins, healthcare providers can more readily integrate these tools into clinical workflows for auxiliary decision-making. This could lead to more precise interventions and improved patient outcomes, particularly in cases requiring customized therapeutic strategies based on individual cardiac physiology.

Moreover, LEADS demonstrates the feasibility of structuring domain knowledge and integrating it into LLM agents, a methodology that can be generalized to other complex biomedical systems. Fields such as neuroscience and pharmacokinetics, which also involve intricate, non-linear dynamics, could benefit from similar agent-driven discovery frameworks. This suggests that LEADS is not just a specialized tool for cardiology but a foundational step toward a broader class of AI systems capable of scientific discovery. The framework marks a transition from AI as a mere pattern recognition tool to AI as an active participant in scientific hypothesis generation and model construction.

Outlook

Experimental validation of the LEADS framework has been conducted on both synthetic and real-world cardiac electrophysiology datasets, yielding promising results. In synthetic data experiments, the framework was tested against three known ground-truth reaction models to evaluate its ability to discover correct structures under ideal conditions. The results demonstrated that LEADS could accurately identify the underlying structures, confirming its effectiveness in controlled environments. In experiments using real clinical data, the framework’s performance was compared against human-designed models and other LLM-based approaches. The LEADS-generated hybrid models significantly outperformed these baselines in terms of prediction accuracy and stability, highlighting the practical utility of the framework in real-world scenarios. Ablation studies further underscored the critical role of the structured action space and the iterative reasoning mechanism in achieving these high levels of performance. These experiments confirmed that embedding domain knowledge into the agent’s decision-making process is essential for generating valid and useful models. The robustness of LEADS in handling high-dimensional, non-linear biomedical data suggests that it is well-suited for the complexities of real-world clinical applications. The framework’s ability to consistently produce physically interpretable and numerically stable models addresses a major concern in the adoption of AI-driven modeling in healthcare. Looking forward, the success of LEADS paves the way for further refinements and expansions of agent-driven modeling techniques. Future research may explore the integration of additional physiological constraints or the application of LEADS to multi-scale modeling, where cellular-level dynamics are linked to organ-level function. As the framework continues to evolve, it has the potential to become a standard tool in the development of personalized digital twins. The establishment of this new automated paradigm for personalized medical modeling represents a significant milestone in the convergence of artificial intelligence and biomedical engineering, offering a scalable solution for the challenges of precision medicine.

The broader impact of LEADS lies in its demonstration of how AI can be guided by scientific principles to produce reliable and interpretable results. By moving beyond black-box predictions, LEADS aligns AI outputs with the rigorous standards of scientific inquiry. This alignment is crucial for gaining the trust of clinicians and regulators, who require transparency and accountability in medical decision-support tools. As the healthcare industry continues to embrace digital transformation, frameworks like LEADS will play a pivotal role in ensuring that AI technologies are both innovative and trustworthy, ultimately contributing to better patient care and more efficient healthcare systems.